Effectiveness of Two Hepatitis B Vaccines in HIV-negative Youths

PHASE2CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Hepatitis B
Interventions
BIOLOGICAL

Recombivax

Participants receive doses of Recombivax at weeks 0 and 24.

BIOLOGICAL

Twinrix

Participants receive doses of Twinrix at weeks 0 and 24.

Trial Locations (11)

10467

Montefiore Medical Center, The Bronx

20010

Children's Hospital National Medical Center, Washington D.C.

21201

University of Maryland, Baltimore

33606

University of Southern Florida College of Medicine, Tampa

60612

Ruth M Rothstein CORE Center/ John H Stroger Jr Hospital, Chicago

70112

Tulane Medical Center, New Orleans

90027

Children's Hospital of Los Angeles, Los Angeles

92103

University of California at San Diego, San Diego

94118

University of California at San Francisco, San Francisco

38105-2794

St. Jude Childrens Research Hospital, Memphis

00936

Unversity of Peurto Rico School of Medicine, San Juan

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

National Institute of Mental Health (NIMH)

NIH

collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT00107042 - Effectiveness of Two Hepatitis B Vaccines in HIV-negative Youths | Biotech Hunter | Biotech Hunter